Over 50% of human cancers contain a mutation in the TP53 gene; individuals with Li-Fraumeni syndrome harbouring germline mutations in TP53 are at an increased risk of developing cancer, including breast cancer, and mouse models with germline knockout of p53 develop normally; however, spontaneous tumours occur at an increased rate [5–10]. This evidence concerns the gene TP53 and cancer.